Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer

NCT00151086 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Estramustine
DRUG: Vinorelbine

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]